Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 5089 to 5100 of 5104 entries
Sorted by: Best Match Show Resources per page
[No title available]

Food science & nutrition

Yamasaki M, Minesaki M, Iwakiri A, Miyamoto Y, Ogawa K, Nishiyama K, Tsend-Ayush C, Oyunsuren T, Li Y, Nakano T, Takeshita M, Arima Y.
PMID: 33282267
Food Sci Nutr. 2020 Oct 26;8(11):6164-6173. doi: 10.1002/fsn3.1909. eCollection 2020 Nov.

Previous study suggested that dietary intake of

Cite
Yamasaki M, Minesaki M, Iwakiri A, et al. . Food Sci Nutr. 2020;8(11):6164-6173doi: 10.1002/fsn3.1909.
Yamasaki, M., Minesaki, M., Iwakiri, A., Miyamoto, Y., Ogawa, K., Nishiyama, K., Tsend-Ayush, C., Oyunsuren, T., Li, Y., Nakano, T., Takeshita, M., & Arima, Y. (2020). . Food science & nutrition, 8(11), 6164-6173. https://doi.org/10.1002/fsn3.1909
Yamasaki, Masao, et al. "." Food science & nutrition vol. 8,11 (2020): 6164-6173. doi: https://doi.org/10.1002/fsn3.1909
Yamasaki M, Minesaki M, Iwakiri A, Miyamoto Y, Ogawa K, Nishiyama K, Tsend-Ayush C, Oyunsuren T, Li Y, Nakano T, Takeshita M, Arima Y. . Food Sci Nutr. 2020 Oct 26;8(11):6164-6173. doi: 10.1002/fsn3.1909. eCollection 2020 Nov. PMID: 33282267; PMCID: PMC7684586.
Copy Download .nbib Format: NLM
A comprehensive review of mechanistic insights into formaldehyde-induced nasal cavity carcinogenicity.

Regulatory toxicology and pharmacology : RTP

Nishikawa A, Nagano K, Kojima H, Ogawa K.
PMID: 33905780
Regul Toxicol Pharmacol. 2021 Jul;123:104937. doi: 10.1016/j.yrtph.2021.104937. Epub 2021 Apr 24.

According to the International Agency for Research on Cancer classification, formaldehyde is a human carcinogen that targets the nasal cavity. In humans and rats, inhaled formaldehyde is primarily deposited in the nasal cavity mucosa, metabolized to the less toxic...

Cite
Nishikawa A, Nagano K, Kojima H, et al. A comprehensive review of mechanistic insights into formaldehyde-induced nasal cavity carcinogenicity. Regul Toxicol Pharmacol. 2021;123:104937doi: 10.1016/j.yrtph.2021.104937.
Nishikawa, A., Nagano, K., Kojima, H., & Ogawa, K. (2021). A comprehensive review of mechanistic insights into formaldehyde-induced nasal cavity carcinogenicity. Regulatory toxicology and pharmacology : RTP, 123104937. https://doi.org/10.1016/j.yrtph.2021.104937
Nishikawa, Akiyoshi, et al. "A comprehensive review of mechanistic insights into formaldehyde-induced nasal cavity carcinogenicity." Regulatory toxicology and pharmacology : RTP vol. 123 (2021): 104937. doi: https://doi.org/10.1016/j.yrtph.2021.104937
Nishikawa A, Nagano K, Kojima H, Ogawa K. A comprehensive review of mechanistic insights into formaldehyde-induced nasal cavity carcinogenicity. Regul Toxicol Pharmacol. 2021 Jul;123:104937. doi: 10.1016/j.yrtph.2021.104937. Epub 2021 Apr 24. PMID: 33905780.
Copy Download .nbib Format: NLM
[Response to Comment on the study titled "Analysis of indium in workplace air by electrothermal atomic absorption spectrometry"].

Sangyo eiseigaku zasshi = Journal of occupational health

Eitaki Y, Nakano M, Omae K, Takebayashi T.
PMID: 34924457
Sangyo Eiseigaku Zasshi. 2021 Dec 18; doi: 10.1539/sangyoeisei.2021-047-L. Epub 2021 Dec 18.

No abstract available.

Cite
Eitaki Y, Nakano M, Omae K, et al. [Response to Comment on the study titled "Analysis of indium in workplace air by electrothermal atomic absorption spectrometry"]. Sangyo Eiseigaku Zasshi. 2021;doi: 10.1539/sangyoeisei.2021-047-L.
Eitaki, Y., Nakano, M., Omae, K., & Takebayashi, T. (2021). [Response to Comment on the study titled "Analysis of indium in workplace air by electrothermal atomic absorption spectrometry"]. Sangyo eiseigaku zasshi = Journal of occupational health, . https://doi.org/10.1539/sangyoeisei.2021-047-L
Eitaki, Yoko, et al. "[Response to Comment on the study titled "Analysis of indium in workplace air by electrothermal atomic absorption spectrometry"]." Sangyo eiseigaku zasshi = Journal of occupational health vol. (2021). doi: https://doi.org/10.1539/sangyoeisei.2021-047-L
Eitaki Y, Nakano M, Omae K, Takebayashi T. [Response to Comment on the study titled "Analysis of indium in workplace air by electrothermal atomic absorption spectrometry"]. Sangyo Eiseigaku Zasshi. 2021 Dec 18; doi: 10.1539/sangyoeisei.2021-047-L. Epub 2021 Dec 18. Japanese. PMID: 34924457.
Copy Download .nbib Format: NLM
Differences in the efficacy and safety of eribulin in patients with soft tissue sarcoma by histological subtype and treatment line.

Molecular and clinical oncology

Nakano K, Hayakawa K, Funauchi Y, Tanizawa T, Ae K, Matsumoto S, Tomomatsu J, Ono M, Taira S, Nishizawa M, Wang X, Ohmoto A, Sato Y, Fukuda N, Urasaki T, Takahashi S.
PMID: 33282288
Mol Clin Oncol. 2021 Jan;14(1):13. doi: 10.3892/mco.2020.2175. Epub 2020 Nov 25.

Clinical evidence regarding eribulin treatment for patients with soft tissue sarcoma (STS) is limited to those with L-sarcoma (leiomyosarcoma and liposarcoma) who have completed at least two chemotherapies. Whether histological subtypes and treatment lines affect the efficacy and safety...

Cite
Nakano K, Hayakawa K, Funauchi Y, et al. Differences in the efficacy and safety of eribulin in patients with soft tissue sarcoma by histological subtype and treatment line. Mol Clin Oncol. 2020;14(1):13doi: 10.3892/mco.2020.2175.
Nakano, K., Hayakawa, K., Funauchi, Y., Tanizawa, T., Ae, K., Matsumoto, S., Tomomatsu, J., Ono, M., Taira, S., Nishizawa, M., Wang, X., Ohmoto, A., Sato, Y., Fukuda, N., Urasaki, T., & Takahashi, S. (2021). Differences in the efficacy and safety of eribulin in patients with soft tissue sarcoma by histological subtype and treatment line. Molecular and clinical oncology, 14(1), 13. https://doi.org/10.3892/mco.2020.2175
Nakano, Kenji, et al. "Differences in the efficacy and safety of eribulin in patients with soft tissue sarcoma by histological subtype and treatment line." Molecular and clinical oncology vol. 14,1 (2021): 13. doi: https://doi.org/10.3892/mco.2020.2175
Nakano K, Hayakawa K, Funauchi Y, Tanizawa T, Ae K, Matsumoto S, Tomomatsu J, Ono M, Taira S, Nishizawa M, Wang X, Ohmoto A, Sato Y, Fukuda N, Urasaki T, Takahashi S. Differences in the efficacy and safety of eribulin in patients with soft tissue sarcoma by histological subtype and treatment line. Mol Clin Oncol. 2021 Jan;14(1):13. doi: 10.3892/mco.2020.2175. Epub 2020 Nov 25. PMID: 33282288; PMCID: PMC7709564.
Copy Download .nbib Format: NLM
Endoscopic Ultrasound-Guided Gastroenterostomy for Afferent Loop Syndrome.

Clinical endoscopy

Shiomi H, Sakai A, Nakano R, Ota S, Kobayashi T, Masuda A, Iijima H.
PMID: 34775697
Clin Endosc. 2021 Nov;54(6):810-817. doi: 10.5946/ce.2021.234. Epub 2021 Nov 15.

Afferent loop syndrome (ALS) is a mechanical obstruction of the afferent limbs after gastrectomy with gastrojejunostomy reconstruction. Patients with cancer recurrence require immediate and less invasive treatment because of their poor condition. Percutaneous transhepatic/transluminal drainage (PTD) and endoscopic enteral...

Cite
Shiomi H, Sakai A, Nakano R, et al. Endoscopic Ultrasound-Guided Gastroenterostomy for Afferent Loop Syndrome. Clin Endosc. 2021;54(6):810-817doi: 10.5946/ce.2021.234.
Shiomi, H., Sakai, A., Nakano, R., Ota, S., Kobayashi, T., Masuda, A., & Iijima, H. (2021). Endoscopic Ultrasound-Guided Gastroenterostomy for Afferent Loop Syndrome. Clinical endoscopy, 54(6), 810-817. https://doi.org/10.5946/ce.2021.234
Shiomi, Hideyuki, et al. "Endoscopic Ultrasound-Guided Gastroenterostomy for Afferent Loop Syndrome." Clinical endoscopy vol. 54,6 (2021): 810-817. doi: https://doi.org/10.5946/ce.2021.234
Shiomi H, Sakai A, Nakano R, Ota S, Kobayashi T, Masuda A, Iijima H. Endoscopic Ultrasound-Guided Gastroenterostomy for Afferent Loop Syndrome. Clin Endosc. 2021 Nov;54(6):810-817. doi: 10.5946/ce.2021.234. Epub 2021 Nov 15. PMID: 34775697; PMCID: PMC8652169.
Copy Download .nbib Format: NLM
Conversion of underwater endoscopic mucosal resection to gel immersion for the resection of a superficial non-ampullary duodenal epithelial tumor.

Endoscopy international open

Tashima T, Nakano Y, Kawasaki T, Jinushi R, Fujita A, Tanisaka Y, Ryozawa S.
PMID: 34917464
Endosc Int Open. 2021 Dec 14;9(12):E1924-E1925. doi: 10.1055/a-1633-3303. eCollection 2021 Dec.

No abstract available.

Cite
Tashima T, Nakano Y, Kawasaki T, et al. Conversion of underwater endoscopic mucosal resection to gel immersion for the resection of a superficial non-ampullary duodenal epithelial tumor. Endosc Int Open. 2021;9(12):E1924-E1925doi: 10.1055/a-1633-3303.
Tashima, T., Nakano, Y., Kawasaki, T., Jinushi, R., Fujita, A., Tanisaka, Y., & Ryozawa, S. (2021). Conversion of underwater endoscopic mucosal resection to gel immersion for the resection of a superficial non-ampullary duodenal epithelial tumor. Endoscopy international open, 9(12), E1924-E1925. https://doi.org/10.1055/a-1633-3303
Tashima, Tomoaki, et al. "Conversion of underwater endoscopic mucosal resection to gel immersion for the resection of a superficial non-ampullary duodenal epithelial tumor." Endoscopy international open vol. 9,12 (2021): E1924-E1925. doi: https://doi.org/10.1055/a-1633-3303
Tashima T, Nakano Y, Kawasaki T, Jinushi R, Fujita A, Tanisaka Y, Ryozawa S. Conversion of underwater endoscopic mucosal resection to gel immersion for the resection of a superficial non-ampullary duodenal epithelial tumor. Endosc Int Open. 2021 Dec 14;9(12):E1924-E1925. doi: 10.1055/a-1633-3303. eCollection 2021 Dec. PMID: 34917464; PMCID: PMC8671000.
Copy Download .nbib Format: NLM
Development of receptive vocabulary and verbal intelligence in Japanese children with unilateral hearing loss.

Auris, nasus, larynx

Takeyama T, Shimada A, Sakamoto Y, Aoki T, Kondo E, Nakano S, Fukuda J, Azuma T, Sato G, Okamoto H, Kitamura Y, Udaka J, Takeda N.
PMID: 34511300
Auris Nasus Larynx. 2021 Sep 09; doi: 10.1016/j.anl.2021.08.002. Epub 2021 Sep 09.

OBJECTIVE: In the past, it was believed that unilateral hearing loss has a minimal impact on the speech and language development in children. However, several studies have suggested that some school-age children with unilateral hearing loss have learning impairments...

Cite
Takeyama T, Shimada A, Sakamoto Y, et al. Development of receptive vocabulary and verbal intelligence in Japanese children with unilateral hearing loss. Auris Nasus Larynx. 2021;doi: 10.1016/j.anl.2021.08.002.
Takeyama, T., Shimada, A., Sakamoto, Y., Aoki, T., Kondo, E., Nakano, S., Fukuda, J., Azuma, T., Sato, G., Okamoto, H., Kitamura, Y., Udaka, J., & Takeda, N. (2021). Development of receptive vocabulary and verbal intelligence in Japanese children with unilateral hearing loss. Auris, nasus, larynx, . https://doi.org/10.1016/j.anl.2021.08.002
Takeyama, Takaaki, et al. "Development of receptive vocabulary and verbal intelligence in Japanese children with unilateral hearing loss." Auris, nasus, larynx vol. (2021). doi: https://doi.org/10.1016/j.anl.2021.08.002
Takeyama T, Shimada A, Sakamoto Y, Aoki T, Kondo E, Nakano S, Fukuda J, Azuma T, Sato G, Okamoto H, Kitamura Y, Udaka J, Takeda N. Development of receptive vocabulary and verbal intelligence in Japanese children with unilateral hearing loss. Auris Nasus Larynx. 2021 Sep 09; doi: 10.1016/j.anl.2021.08.002. Epub 2021 Sep 09. PMID: 34511300.
Copy Download .nbib Format: NLM
Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders in patients treated with methotrexate: a retrospective, multi-center descriptive study.

Modern rheumatology

Nakano K, Tanaka Y, Saito K, Kaneko Y, Saito S, Tanaka M, Saito R, Fujii T, Kuramoto N, Sugimoto N, Takada H, Harigai M, Sasaki S, Suzuki Y.
PMID: 34919717
Mod Rheumatol. 2020 Dec 07; doi: 10.1080/14397595.2020.1847775. Epub 2020 Dec 07.

OBJECTIVES: To identify the optimal treatment for rheumatoid arthritis (RA) after the regression of lymphoproliferative disorders (LPDs).METHODS: The subjects were 232 patients with RA who developed LPD between 2000 and 2017 at seven hospitals participating in the LPD-WG study....

Cite
Nakano K, Tanaka Y, Saito K, et al. Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders in patients treated with methotrexate: a retrospective, multi-center descriptive study. Mod Rheumatol. 2020;doi: 10.1080/14397595.2020.1847775.
Nakano, K., Tanaka, Y., Saito, K., Kaneko, Y., Saito, S., Tanaka, M., Saito, R., Fujii, T., Kuramoto, N., Sugimoto, N., Takada, H., Harigai, M., Sasaki, S., & Suzuki, Y. (2020). Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders in patients treated with methotrexate: a retrospective, multi-center descriptive study. Modern rheumatology, . https://doi.org/10.1080/14397595.2020.1847775
Nakano, Kazuhisa, et al. "Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders in patients treated with methotrexate: a retrospective, multi-center descriptive study." Modern rheumatology vol. (2020). doi: https://doi.org/10.1080/14397595.2020.1847775
Nakano K, Tanaka Y, Saito K, Kaneko Y, Saito S, Tanaka M, Saito R, Fujii T, Kuramoto N, Sugimoto N, Takada H, Harigai M, Sasaki S, Suzuki Y. Treatment of rheumatoid arthritis after regression of lymphoproliferative disorders in patients treated with methotrexate: a retrospective, multi-center descriptive study. Mod Rheumatol. 2020 Dec 07; doi: 10.1080/14397595.2020.1847775. Epub 2020 Dec 07. PMID: 34919717.
Copy Download .nbib Format: NLM
The association between the extent of lipidic burden and delta-fractional flow reserve: analysis from coronary physiological and near-infrared spectroscopic measures.

Cardiovascular diagnosis and therapy

Murai K, Kataoka Y, Nakaoku Y, Nishimura K, Kitahara S, Iwai T, Nakamura H, Hosoda H, Hirayama A, Matama H, Doi T, Nakashima T, Honda S, Fujino M, Nakao K, Yoneda S, Nishihira K, Kanaya T, Otsuka F, Asaumi Y, Tsujita K, Noguchi T, Yasuda S.
PMID: 33968615
Cardiovasc Diagn Ther. 2021 Apr;11(2):362-372. doi: 10.21037/cdt-20-1024.

BACKGROUND: Vulnerable plaque features including lipidic plaque have been shown to affect fractional flow reserve (FFR). Given that formation and propagation of lipid plaque is accompanied by endothelial dysfunction which impairs vascular tone, the degree of lipidic burden may...

Cite
Murai K, Kataoka Y, Nakaoku Y, et al. The association between the extent of lipidic burden and delta-fractional flow reserve: analysis from coronary physiological and near-infrared spectroscopic measures. Cardiovasc Diagn Ther. 2021;11(2):362-372doi: 10.21037/cdt-20-1024.
Murai, K., Kataoka, Y., Nakaoku, Y., Nishimura, K., Kitahara, S., Iwai, T., Nakamura, H., Hosoda, H., Hirayama, A., Matama, H., Doi, T., Nakashima, T., Honda, S., Fujino, M., Nakao, K., Yoneda, S., Nishihira, K., Kanaya, T., Otsuka, F., Asaumi, Y., Tsujita, K., Noguchi, T., & Yasuda, S. (2021). The association between the extent of lipidic burden and delta-fractional flow reserve: analysis from coronary physiological and near-infrared spectroscopic measures. Cardiovascular diagnosis and therapy, 11(2), 362-372. https://doi.org/10.21037/cdt-20-1024
Murai, Kota, et al. "The association between the extent of lipidic burden and delta-fractional flow reserve: analysis from coronary physiological and near-infrared spectroscopic measures." Cardiovascular diagnosis and therapy vol. 11,2 (2021): 362-372. doi: https://doi.org/10.21037/cdt-20-1024
Murai K, Kataoka Y, Nakaoku Y, Nishimura K, Kitahara S, Iwai T, Nakamura H, Hosoda H, Hirayama A, Matama H, Doi T, Nakashima T, Honda S, Fujino M, Nakao K, Yoneda S, Nishihira K, Kanaya T, Otsuka F, Asaumi Y, Tsujita K, Noguchi T, Yasuda S. The association between the extent of lipidic burden and delta-fractional flow reserve: analysis from coronary physiological and near-infrared spectroscopic measures. Cardiovasc Diagn Ther. 2021 Apr;11(2):362-372. doi: 10.21037/cdt-20-1024. PMID: 33968615; PMCID: PMC8102241.
Copy Download .nbib Format: NLM
Concomitant use of tea catechins affects absorption and serum triglyceride-lowering effects of monoglucosyl hesperidin.

Food & function

Katada S, Oishi S, Yanagawa K, Ishii S, Oki M, Matsui Y, Osaki N, Takano K, Hibi M.
PMID: 34606551
Food Funct. 2021 Oct 04;12(19):9339-9346. doi: 10.1039/d1fo01917a.

The present study investigated whether combined ingestion of green tea catechins (GTC) and monoglucosyl hesperidin (GHES) influences the pharmacokinetic parameters of polyphenols and serum triglycerides (TG). We conducted 2 randomized, controlled trials. Study 1: 8 healthy male subjects participated...

Cite
Katada S, Oishi S, Yanagawa K, et al. Concomitant use of tea catechins affects absorption and serum triglyceride-lowering effects of monoglucosyl hesperidin. Food Funct. 2021;12(19):9339-9346doi: 10.1039/d1fo01917a.
Katada, S., Oishi, S., Yanagawa, K., Ishii, S., Oki, M., Matsui, Y., Osaki, N., Takano, K., & Hibi, M. (2021). Concomitant use of tea catechins affects absorption and serum triglyceride-lowering effects of monoglucosyl hesperidin. Food & function, 12(19), 9339-9346. https://doi.org/10.1039/d1fo01917a
Katada, Shun, et al. "Concomitant use of tea catechins affects absorption and serum triglyceride-lowering effects of monoglucosyl hesperidin." Food & function vol. 12,19 (2021): 9339-9346. doi: https://doi.org/10.1039/d1fo01917a
Katada S, Oishi S, Yanagawa K, Ishii S, Oki M, Matsui Y, Osaki N, Takano K, Hibi M. Concomitant use of tea catechins affects absorption and serum triglyceride-lowering effects of monoglucosyl hesperidin. Food Funct. 2021 Oct 04;12(19):9339-9346. doi: 10.1039/d1fo01917a. PMID: 34606551.
Copy Download .nbib Format: NLM
Multimolecular-Targeted Agents for Intermediate-Stage Hepatocellular Carcinoma Influence Time to Stage Progression and Overall Survival.

Oncology

Shimose S, Iwamoto H, Tanaka M, Niizeki T, Shirono T, Kajiwara A, Noda Y, Kamachi N, Okamura S, Nakano M, Kuromatsu R, Kawaguchi T, Koga H, Torimura T.
PMID: 34518483
Oncology. 2021;99(12):756-765. doi: 10.1159/000518612. Epub 2021 Sep 08.

Background & Aims: Intermediate hepatocellular carcinoma (HCC) treatment has become complicated due to the development of various molecular-targeted agents (MTAs). We aimed to determine whether the administration of MTAs in patients with intermediate-stage HCC contributed to the prevention of...

Cite
Shimose S, Iwamoto H, Tanaka M, et al. Multimolecular-Targeted Agents for Intermediate-Stage Hepatocellular Carcinoma Influence Time to Stage Progression and Overall Survival. Oncology. 2021;99(12):756-765doi: 10.1159/000518612.
Shimose, S., Iwamoto, H., Tanaka, M., Niizeki, T., Shirono, T., Kajiwara, A., Noda, Y., Kamachi, N., Okamura, S., Nakano, M., Kuromatsu, R., Kawaguchi, T., Koga, H., & Torimura, T. (2021). Multimolecular-Targeted Agents for Intermediate-Stage Hepatocellular Carcinoma Influence Time to Stage Progression and Overall Survival. Oncology, 99(12), 756-765. https://doi.org/10.1159/000518612
Shimose, Shigeo, et al. "Multimolecular-Targeted Agents for Intermediate-Stage Hepatocellular Carcinoma Influence Time to Stage Progression and Overall Survival." Oncology vol. 99,12 (2021): 756-765. doi: https://doi.org/10.1159/000518612
Shimose S, Iwamoto H, Tanaka M, Niizeki T, Shirono T, Kajiwara A, Noda Y, Kamachi N, Okamura S, Nakano M, Kuromatsu R, Kawaguchi T, Koga H, Torimura T. Multimolecular-Targeted Agents for Intermediate-Stage Hepatocellular Carcinoma Influence Time to Stage Progression and Overall Survival. Oncology. 2021;99(12):756-765. doi: 10.1159/000518612. Epub 2021 Sep 08. PMID: 34518483.
Copy Download .nbib Format: NLM
Long Carbon-Carbon Bonding beyond 2 Å in Tris(9-fluorenylidene)methane.

Journal of the American Chemical Society

Kubo T, Suga Y, Hashizume D, Suzuki H, Miyamoto T, Okamoto H, Kishi R, Nakano M.
PMID: 34459597
J Am Chem Soc. 2021 Sep 08;143(35):14360-14366. doi: 10.1021/jacs.1c07431. Epub 2021 Aug 30.

We report on our investigation of C-C bonding longer than 2.0 Å, which can be realized by perpendicularly facing two fluorenyl rings in the title compound. A small orbital overlap between the distantly positioned carbon atoms is observed as...

Cite
Kubo T, Suga Y, Hashizume D, et al. Long Carbon-Carbon Bonding beyond 2 Å in Tris(9-fluorenylidene)methane. J Am Chem Soc. 2021;143(35):14360-14366doi: 10.1021/jacs.1c07431.
Kubo, T., Suga, Y., Hashizume, D., Suzuki, H., Miyamoto, T., Okamoto, H., Kishi, R., & Nakano, M. (2021). Long Carbon-Carbon Bonding beyond 2 Å in Tris(9-fluorenylidene)methane. Journal of the American Chemical Society, 143(35), 14360-14366. https://doi.org/10.1021/jacs.1c07431
Kubo, Takashi, et al. "Long Carbon-Carbon Bonding beyond 2 Å in Tris(9-fluorenylidene)methane." Journal of the American Chemical Society vol. 143,35 (2021): 14360-14366. doi: https://doi.org/10.1021/jacs.1c07431
Kubo T, Suga Y, Hashizume D, Suzuki H, Miyamoto T, Okamoto H, Kishi R, Nakano M. Long Carbon-Carbon Bonding beyond 2 Å in Tris(9-fluorenylidene)methane. J Am Chem Soc. 2021 Sep 08;143(35):14360-14366. doi: 10.1021/jacs.1c07431. Epub 2021 Aug 30. PMID: 34459597.
Copy Download .nbib Format: NLM
Showing 5089 to 5100 of 5104 entries